ストックスクリーナーアプリを入手
0.4574
4.62%
-0.0259
前日終値:
$0.4832
開ける：
$0.4821
24時間の取引高:
120.50K
Relative Volume:
0.16
時価総額：
$23.67M
収益：
$110.97M
当期純損益:
$-33.18M
株価収益率:
-0.6957
EPS:
-0.6574
ネットキャッシュフロー:
$-11.80M
1週間 パフォーマンス:
+12.25%
1か月 パフォーマンス:
-18.55%
6か月 パフォーマンス:
-86.20%
1年 パフォーマンス:
-78.46%
1日の値動き範囲:
$0.45
$0.4896
1週間の範囲:
$0.4139
$0.54
52週間の値動き範囲:
$0.40
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH vs TMO, DHR, IDXX, NTRA, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
0.4608 | 24.48M | 110.97M | -33.18M | -11.80M | -0.6574 |
TMO
Thermo Fisher Scientific Inc
|
515.39 | 194.52B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
192.55 | 140.09B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
565.98 | 44.00B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
283.90 | 40.00B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
375.31 | 37.24B | 3.77B | 449.25M | 240.68M | 7.8556 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-17 | 開始されました | Craig Hallum | Buy |
| 2024-10-31 | 開始されました | Lake Street | Buy |
| 2023-05-31 | 開始されました | TD Cowen | Outperform |
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
Mdxhealth Sa (MDXH) 最新ニュース
MDxHealth Study Backs Prostate Cancer Test - Orange County Business Journal
MDxHealth SA(NasdaqCM: MDXH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Mdxhealth study published in European Urology Oncology - Investing.com
Mdxhealth study published in European Urology Oncology By Investing.com - Investing.com Canada
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial - The Manila Times
Mdxhealth study finds 92% six-year freedom from failure - Stock Titan
MDxHealth SA(NasdaqCM: MDXH) added to Russell 3000E Value Benchmark - marketscreener.com
MDxHealth S.A. Actuals & Estimates (NASDAQ:MDXH) - TradingView
MDxHealth S.A. Actuals & Estimates (SWB:O6C1) - TradingView
MDxHealth SA (MDXH) Valuation: PE, PB & Fair Value Analysis - TradingKey
MDXH Forecast — Price Target — Prediction for 2027 - TradingView
MDxHealth SA (MDXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MDXH PE Ratio & Valuation, Is MDXH Overvalued - Intellectia AI
MDxHealth SA (MDXH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MDxHealth StockThursday technical snapshot around key support - AD HOC NEWS
MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MDxHealth SA (MDXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MDxHealth SA (MDXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MDxHealth SA (MDXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MDxHealth SA (MDXH) Institutional Confidence - TradingKey
MDxHealth (MDXH) Hovers Near Key Support Level After Marginal DeclineWyckoff Upthrust - newsline.com
· Analyst Forecast - MLQ.ai
MDxHealth (MDXH) Slips 5.7% as Shares Test Key Support at $0.54Ease of Movement - newsline.com
MDxHealth (MDXH) director Michael Holder receives 10,000 share option grant - Stock Titan
MDxHealth (NASDAQ: MDXH) grants Joseph Sollee 237,100 share options - Stock Titan
Director Don M. Hardison granted 10,000 MDxHealth (MDXH) options at $0.76 - Stock Titan
MDxHealth (MDXH) awards new share options to finance VP - Stock Titan
MDxHealth (NASDAQ: MDXH) CEO granted 942,200 share options at $0.76 strike - Stock Titan
MDxHealth (MDXH) director-linked entity receives 10,000 share options at $0.76 - Stock Titan
MDxHealth (NASDAQ: MDXH) grants CCO John Bellano 333,000 share options - Stock Titan
MDxHealth (MDXH) director granted options on 10,000 shares - Stock Titan
MDxHealth (MDXH) director Koen Hoffman awarded 10,000 share options via Ahok BV - Stock Titan
MDxHealth (MDXH) Edges Higher as Stock Tests Key Resistance Near $0.80Sentiment Shift - thelegaladvocate.com
MDxHealth (MDXH) VP Brendan O’Connell files initial Form 3 ownership report - Stock Titan
MDXHMDxHealth SA Stock Price and Quote - Finviz
MDxHealth (MDXH) Slides 6.25% as Cancer Diagnostics Stock Tests Key Support LevelEnding Diagonal - thelegaladvocate.com
MDxHealth to Shut Down Resolve UTI Business - Orange County Business Journal
MDXHealth Q1 2026 Earnings: EPS Miss Weighs on Shares as Company Navigates Diagnostic MarketEarnings Call Transcript - The Legal Advocate
MDxHealth SA (MDXH) Stock Analysis: -3.98% Loss — Key Levels 2026-05-21Fair Value Gap - Newser
Mdxhealth Refocuses on Prostate Franchise Amid Headwinds - The Globe and Mail
MDxHealth SA (MDXH) Stock Analysis: +4.85% Gain — What to Watch 2026-05-20Upthrust Pattern - Newser
Earnings call transcript: MDxHealth Q1 2026 sees significant stock drop amid earnings miss - Investing.com Canada
MDxHealth SA (MDXH) Slips -1.62%, Testing $0.84 Support 2026-05-18Verified Signals - Newser
MDxHealth SA (MDXH) Q1 2026 Earnings: Miss Sparks ConcernCrowd Trend Signals - Newser
MDxHealth SA (MDXH) Q1 2026 Results Fall Short — EPS $-0.17, Revenue $N/ADividend Cut Risk - Newser
MDxHealth SA stock (US55278X1072): cancer diagnostics specialist back in focus after capital raise - AD HOC NEWS
MDxHealth SA (MDXH) Q1 2026 Earnings Miss: EPS $-0.19 vs $-0.15 Expected - Newser
MDxHealth Exits UTI Business Amid Medicare Reimbursement Dispute - HarianBasis.co
MDxHealth S.A. (NASDAQ:MDXH) Q1 2026 Earnings Call Transcript - Insider Monkey
Mdxhealth Earnings Call: Prostate Pivot Amid Pressure - The Globe and Mail
Mdxhealth Sa (MDXH) 財務データ
収益
当期純利益
現金流量
EPS
1.60%
0.44%
大文字化:
|
ボリューム (24 時間):